Granules India has received the inspection report from INFARMED (InstitutoNacional da Farmacia E Do Medicamento), Portugal with 11 observations. The Gagillapur facility manufactures Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs). INFARMED Portugal had conducted a renewal inspection on the company’s facility located at Gagillapur, Telangana, India.
The company has initiated necessary steps to address the observations of the inspection agency and will submit its response with a corrective and preventive action plan within stipulated time. The company will also be requesting the INFARMED for re-inspection of the Gagillapur facility at the earliest.
Granules India is a pharmaceutical company with presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs).
